Insider Ownership Details

This table shows the list known insiders, and is generated automatically from filings disclosed to the SEC. In addition to the names, most recent title, and director, officer, or 10% owner designation, we provide the latest disclosed holdings.

Name Shares Options
Lee's Pharmaceutical Holdings Ltd By Subsidiary 14,450,599 0
LPH II Investments Ltd 4,008,234 0
Huang James Via Panacea Venture Healthcare Fund I L.P. 2,336,853 0
Center Laboratories, Inc. By Bioengine Capital Inc. 1,239,088 0
Center Laboratories, Inc. 1,239,088 0
CAPETOLA ROBERT J 840,833 0
Huang James 291,281 0
Fraser Craig 221,558 0
Simonson Steven 83,602 0
COOPER JOHN G 64,313 0
Tattory John A 26,495 0
PEACOCK BRUCE 8,886 0
Leone John R 7,473 0
Joseph Mahady M 7,455 0
ESTEVE ANTONIO PHD 4,590 60,000
Hamill John P. 3,500 0
Schreiber Brian D 2,069 0
Geffken Daniel E. 2,069 0
Curtis Eric 1,291 0
Templeton Mary B Esq 1,134 0
Panacea Venture Healthcare Fund I, L.P. 0 0
SCOTT ROBERT A 0 0
ROSENTHALE MARVIN E 0 15,000
ESTEVE ANTONIO PHD By corporation 0 0
Williams Leslie J. 0 0
Huang James Via Rui Jin (HK) Consulting Management Company Limited 0 0
Loh Evan 0 0
Cole Kathy 0 0
Clayton Russell 0 0
LINK MAX 0 60,000
Amick W Thomas 0 0
Huang James Via Panacea Venture Healthcare Fund I L.P 0 0
KPCB China Holdings II, Ltd. 0 0
0 0
Lee's Pharmaceutical Holdings Ltd 0 0
Bioengine Capital Inc. 0 0
Miller Thomas F 0 0
LPH Investments Ltd 0 0
CARMAN DIANE 0 0
Hoy Thomas 0 0
Magee Michael L 0 0
Lee's Pharmaceutical International Ltd 0 0
 

While Insider sales are normal part of tax harvesting and is part of compensation of executives - A large number of transactions would indicate that the management isnt convinced that the price will go up and hence reducing their holding. This would be a possible indicator or fall in price

Recent Insider Sales

Name Shares Price Date
 

Recent Insider Purchases

Insider buys arent usual, since it indicates a high conviction by the management that they believe the price will go up eventually. Usually a good sign that investors should consider this as a factor to purchase a stock, especially if the current SP is lower than the price the management bought these at. The table below doesnt include any Stock Options or RSUs. They're just open market purchases by the insiders.

Name Shares Price Date